Cresset Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $526K | Buy |
30,152
+1,900
| +7% | +$33.2K | ﹤0.01% | 1048 |
|
|
2025
Q1 | $355K | Buy |
28,252
+500
| +2% | +$6.29K | ﹤0.01% | 1218 |
|
|
2024
Q4 | $293K | Buy |
27,752
+3,270
| +13% | +$34.5K | ﹤0.01% | 1341 |
|
|
2024
Q3 | $355K | Hold |
24,482
| – | – | ﹤0.01% | 1687 |
|
|
2024
Q2 | $208K | Buy |
+24,482
| New | +$208K | ﹤0.01% | 1840 |
|